Axsome Therapeutics Inc.
AXSM | NASDAQ
$132.57
-$11.86 (-8.21%)
Nov 2, 2026, 2:32 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 776.57M | 708.24M | 638.5M | 561.26M | 495.03M | 432.16M | 385.69M | 338.46M | 291.49M | 251.02M | 270.6M | 223.44M | 182.49M | 144.61M | 50.04M | 25.67M | 8.82M | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 52.53M | 52.41M | 47.48M | 45.66M | 42.19M | 36.8M | 33.3M | 30.17M | 28.26M | 24.81M | 26.07M | 20.98M | 16.37M | 12.75M | 5.2M | 2.91M | 983K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 724.04M | 655.82M | 591.02M | 515.6M | 452.85M | 395.36M | 352.39M | 308.29M | 263.23M | 226.22M | 244.54M | 202.46M | 166.12M | 131.86M | 44.84M | 22.76M | 7.84M | n/a | n/a | n/a | n/a | n/a |
Operating Income | -188.54M | -175.61M | -169.24M | -212.42M | -228.94M | -270.27M | -280.56M | -306.22M | -305.72M | -292.73M | -231.83M | -193.47M | -173.76M | -147.88M | -179.8M | -152.49M | -143.49M | -135.15M | -124.71M | -119.84M | -107.56M | -94.49M |
Interest Income | 2.04M | 2.04M | 2.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -191.09M | -188.83M | -183.7M | -230.4M | -247.78M | -278.19M | -287.13M | -311.28M | -309.56M | -298M | -238.28M | -200.54M | -182.49M | -156.14M | -187.13M | -159.87M | -149.93M | -140.78M | -130.4M | -125.59M | -113.63M | -99.68M |
Net Income | -191.64M | -188.3M | -183.17M | -229.53M | -246.9M | -278.27M | -287.22M | -310.96M | -308.55M | -296.38M | -239.24M | -201.83M | -184.45M | -158.72M | -187.13M | -159.87M | -149.93M | -140.78M | -130.4M | -125.59M | -113.63M | -99.68M |
Selling & General & Admin | 712.67M | 634.81M | 570.6M | 514.57M | 459.9M | 433.18M | 411.36M | 384.9M | 372.52M | 347.9M | 323.12M | 297.81M | 255.52M | 207.74M | 159.25M | 116.58M | 95.92M | 81.1M | 66.65M | 58.18M | 44.28M | 35.18M |
Research & Development | 187.86M | 191.17M | 183.28M | 189.49M | 194.72M | 195.03M | 187.08M | 162.87M | 146.25M | 116.98M | 97.94M | 81.83M | 67.94M | 63.16M | 57.95M | 57.04M | 55.34M | 54.05M | 58.06M | 61.66M | 63.28M | 59.32M |
Other Expenses | 12.06M | 5.45M | 6.38M | 23.96M | 27.16M | 37.42M | 34.52M | 66.74M | 50.17M | 54.06M | 55.29M | 16.29M | 16.42M | 8.85M | 7.44M | 1.63M | 66K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 912.58M | 831.43M | 760.25M | 728.02M | 681.78M | 665.63M | 632.95M | 614.51M | 568.94M | 518.94M | 476.36M | 395.93M | 339.88M | 279.74M | 224.64M | 175.25M | 151.32M | 135.15M | 124.71M | 119.84M | 107.56M | 94.49M |
Interest Expense | 5.02M | 5.31M | 6.56M | 7.6M | 8.45M | 7.92M | 6.57M | 5.06M | 3.84M | 5.27M | 6.45M | 7.07M | 8.73M | 8.25M | 7.33M | 7.38M | 6.44M | 5.62M | 5.7M | 5.8M | 4.88M | 3.99M |
Selling & Marketing Expenses | 41.4M | 77.4M | 77.4M | 77.4M | 36M | n/a | n/a | n/a | n/a | 26.7M | 26.7M | 26.7M | 26.7M | -583 | -314 | -314 | 129 | 269 | 286.92K | 286.92K | 286.92K | 286.92K |
Cost & Expenses | 965.11M | 883.85M | 807.73M | 773.69M | 723.97M | 702.43M | 666.26M | 644.68M | 597.2M | 543.75M | 502.43M | 416.91M | 356.25M | 292.5M | 229.84M | 178.16M | 152.31M | 135.15M | 124.71M | 119.84M | 107.56M | 94.49M |
Income Tax Expense | 558K | -530K | -530K | -875K | -875K | 85K | 85K | -325K | -1M | -1.62M | 960K | 1.29M | 1.96M | 2.58M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 51.5M | 51.2M | 50.63M | 50.02M | 49.44M | 48.87M | 48.54M | 48.14M | 47.57M | 47.39M | 47.33M | 47.12M | 43.67M | 43.52M | 43.45M | 41.7M | 39.08M | 38.32M | 37.76M | 37.68M | 37.6M | 37.43M |
Shares Outstanding (Diluted) | 51.5M | 51.2M | 50.63M | 50.02M | 49.44M | 48.87M | 48.54M | 48.14M | 47.57M | 47.39M | 47.33M | 47.12M | 43.67M | 43.52M | 43.45M | 41.7M | 39.08M | 38.32M | 37.76M | 37.68M | 37.6M | 37.43M |
EPS (Basic) | -3.75 | -3.73 | -3.69 | -4.67 | -5.07 | -5.77 | -5.99 | -6.53 | -6.51 | -6.38 | -5.20 | -4.53 | -4.28 | -3.80 | -4.57 | -4.06 | -3.92 | -3.72 | -3.47 | -3.35 | -3.03 | -2.66 |
EPS (Diluted) | -3.75 | -3.73 | -3.69 | -4.67 | -5.07 | -5.77 | -5.99 | -6.53 | -6.51 | -6.38 | -5.20 | -4.53 | -4.28 | -3.80 | -4.57 | -4.06 | -3.92 | -3.72 | -3.47 | -3.35 | -3.03 | -2.66 |
EBITDA | -179.79M | -172.72M | -166.48M | -212.35M | -228.53M | -262.01M | -272.6M | -298.59M | -298.41M | -285.27M | -224.53M | -185.9M | -166.25M | -142.13M | -175.4M | -149.8M | -142.17M | -133.96M | -123.55M | -118.88M | -108.14M | -95.34M |
EBIT | -186.07M | -181.24M | -174.86M | -220.52M | -237.04M | -270.27M | -280.56M | -306.22M | -305.72M | -292.73M | -231.83M | -193.47M | -173.76M | -147.88M | -179.8M | -152.49M | -143.49M | -135.15M | -124.71M | -119.79M | -108.76M | -95.69M |
Depreciation & Amortization | 6.28M | 8.52M | 8.38M | 8.18M | 8.51M | 8.26M | 7.96M | 7.63M | 7.31M | 7.46M | 7.29M | 7.57M | 7.51M | 5.75M | 4.4M | 2.69M | 1.31M | 1.2M | 1.16M | 909.49K | 615.27K | 343.37K |
Add to Watchlist
Select watchlists to add or remove AXSM